Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2011

Jan 4, 2011

34301_dirs_2011-01-04_be19d091-b0a7-4944-aee8-66bb411264b0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-01-01

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-01-01 Restricted Stock Award (Common Stock) A 6000 Acquired 146101 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-01-01 Non-Qualified Stock Option (right to buy) $5.19 A 15000 Acquired 2021-01-01 Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20911 Indirect
Common Stock 34909 Indirect

Footnotes

F1: The Restricted Stock Award ("Award") vests in full on December 31, 2011, subject to the terms of the Company's 2004 Equity Incentive Plan.

F2: These securities are owned by David Rickey, TTEE FBO the David Rickey Trust.

F3: These securities are owned by the Dave Rickey and Daughters Foundation.

F4: These securities are owned by David M Rickey, Trustee FBO The Rickey Annunity Trust.

F5: The stock options vest 1/24th each month from date of grant, subject to the terms of the 2004 Equity Incentive Plan.